This medical video looks into targeted Cancer therapies which gives doctors a better way to tailor Cancer treatment.
Read the full transcript »
Jennifer Matthews: 27-year-old Anthony Sanchez was in the prime of his life when he was diagnosed with Hodgkin's Disease, cancer of the lymph nodes. Anthony Sanchez: I was surprised but not worried it was going to be the end of me. Just worried how it was going to be taken care of. Jennifer Matthews: Doctors at the University of Miami are treating him with an experimental treatment called SGN 30. It targets only cancer cells with a specific marker called CD 30 and leaves healthy cells alone. Dr. Hugo Fernandez: So cells that normally don't contain this will just continue growing happily, whereas with chemotherapy, it's going to affect all the cells in the blood system. It's going to affect the hair system, the cells in the mouth, in the gut, and cause damage. Jennifer Matthews: An early study showed the results doctors were hoping for: the drug shrank the tumors in patients whose cancer kept coming back after standard treatment. And it did it without the harmful effects of other treatments. Dr. Hugo Fernandez: This offers patient who have had chemotherapy, had high doses of therapy, even transplantation, another alternative to treat the disease. Anthony Sanchez: I'm lucky to feel no side effects basically, almost compared to when I see other people and see how it affects them. I consider myself lucky and blessed. Jennifer Matthews: Anthony's not cured yet, but he's glad to have an easier alternative to keep his cancer in check. This is Jennifer Matthews reporting.